Stock listing

Pulse Biosciences, Inc

Selected listing: 6L8 · GETTEX · EUR · DE

Pulse Biosciences, Inc (gettex:6L8), Health Technology. Latest release Sep 15, 2026: Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study…

6L8:GETTEXEURDEUpdated October 2, 2026

Ticker: gettex:6L8
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: gettex
Currency: EUR

Latest news from Pulse Biosciences, Inc

Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules

September 15, 2026

Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results

August 6, 2026

Pulse Biosciences to Present at Canaccord Genuity’s 46th Annual Growth Conference

July 30, 2026

Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study

July 29, 2026

Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026

July 21, 2026

All Pulse Biosciences, Inc news →

Events

Replays

Pulse Biosciences, Inc (PLSE) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 04:30 PM ET
Watch
Pulse Biosciences, Inc (PLSE) Q1 2026 Earnings Call
Thu, May 07, 2026 · 04:30 PM ET
Watch
Pulse Biosciences, Inc (PLSE) Q4 2025 Earnings Call
Thu, Feb 19, 2026 · 04:30 PM ET
Watch

Research Pulse Biosciences, Inc

Pulse Biosciences, Inc company profile

View the public company page for Pulse Biosciences, Inc on 6ix.

Pulse Biosciences, Inc news

Read company news and market updates connected to Pulse Biosciences, Inc.

Pulse Biosciences, Inc investor events

Find investor webinars, events, and replay context for Pulse Biosciences, Inc.